ACA vs GILD · P/E 57, rev $2.88B vs P/E 18, rev $29.44B
Arcosa Inc (ACA) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Arcosa Inc (ACA) is a engineering & construction company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported ACA revenue for 2025-12-31 was $2.88B. Net income was $208.4M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. ACA currently screens at market cap $4.39B and trailing P/E 56.6.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
ACA currently screens at market cap $4.39B and trailing P/E 56.6. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the ACA and GILD stock pages for the full models.
Not investment advice.